(Q33487903)

English

Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

Europe PubMed Central

Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Helicobacter pylori

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

author name string

H D Langtry

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

M I Wilde

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

publication date

1 September 1998

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

56

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

447-486

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

A double-blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis: a multicentre trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological therapy of Helicobacter pylori infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How to treat Helicobacter pylori infection--should treatment strategies be based on testing bacterial susceptibility? A personal viewpoint

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Who should be treated for Helicobacter pylori infection? A review of consensus conferences and guidelines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A United States multicentre trial of dual and proton pump inhibitor-based triple therapies for Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helicobacter pylori eradication--comparison of three drug regimens and symptomatic assessment in duodenitis and antral gastritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection: the significance of imidazole resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction study of lomefloxacin and ciprofloxacin with omeprazole and comparative pharmacokinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maintenance treatment for gastro-oesophageal reflux disease. A placebo-controlled evaluation of 10 milligrams omeprazole once daily in general practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual therapy versus triple therapy for Helicobacter pylori-associated duodenal ulcers

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of five maintenance therapies for reflux esophagitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole versus ranitidine: short-term triple-therapy in patients with Helicobacter pylori-positive duodenal ulcers

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative trial of short term therapy with omeprazole plus either amoxycillin or azithromycin for Helicobacter pylori eradication

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of two 1-week low-dose omeprazole triple therapies--optimal treatment for Helicobacter pylori infection?

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does pretreatment with omeprazole decrease the chance of eradication of Helicobacter pylori in peptic ulcer patients?

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-day high-dose combined therapy of Helicobacter pylori infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Additive effect of clarithromycin combined with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole treatment of children with peptic esophagitis refractory to ranitidine therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pantoprazole and omeprazole in the treatment of reflux oesophagitis: a European multicentre study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole for severe reflux esophagitis in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lethargy with omeprazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of colloidal bismuth subnitrate in the eradication rates of Helicobacter pylori infection-associated duodenal ulcer using a short treatment regimen with omeprazole and clarithromycin: a randomized study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gait ataxia during omeprazole therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of short- and long-term treatment with omeprazole on the absorption and serum levels of cobalamin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Helicobacter pylori infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double-blind, randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Doubling the omeprazole dose (40 mg b.d. vs. 20 mg b.d.) in dual therapy with amoxycillin increases the cure rate of Helicobacter pylori infection in duodenal ulcer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole-associated agranulocytosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What are the treatment goals for Helicobacter pylori infection?

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Wrap session: is the Nissen slipping? Can medical treatment replace surgery for severe gastroesophageal reflux disease in children?

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effective 2-wk therapy for Helicobacter pylori disease in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exfoliative dermatitis related to omeprazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid eradication of Helicobacter pylori infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of omeprazole on the pharmacokinetics of itraconazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of intravenous omeprazole in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helicobacter pylori and peptic ulcer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole plus amoxicillin versus triple therapy eradicates Helicobacter pylori in the Chinese with peptic ulcer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole-based dual and triple therapy for the treatment of Helicobacter pylori infection in peptic ulcer disease: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The medical management of gastro-oesophageal reflux

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of Helicobacter pylori infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic analysis of alternative treatments for persistent gastro-oesophageal reflux disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole-amoxycillin therapy for eradication of Helicobacter pylori in duodenal ulcer bleeding: preliminary results of a pilot study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of nonsteroidal anti-inflammatory drug-associated lesions: a cost-effectiveness perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weekend therapy for the treatment of Helicobacter pylori infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole or ranitidine plus metoclopramide for patients with severe erosive oesophagitis. A cost-effectiveness analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole induces altered bile acid metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lansoprazole 30 mg versus omeprazole 40 mg in the treatment of reflux oesophagitis grade II, III and IVa (a Dutch multicentre trial). Dutch Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eradication of Helicobacter pylori in peptic ulcer disease with amoxycillin, 2.0 g, and omeprazole, 80 or 120 mg: a prospective randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose omeprazole plus amoxicillin or clarithromycin cures Helicobacter pylori infection in duodenal ulcer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer]

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized blinded comparison of omeprazole and ranitidine in the treatment of chronic esophageal stricture secondary to acid peptic esophagitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

US double-blind, controlled trials of omeprazole and amoxycillin for treatment of Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short report: omeprazole-tetracycline combinations are inadequate as therapy for Helicobacter pylori infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of omeprazole in the pediatric population

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reflux esophagitis in infants and children: a report from the Working Group on Gastro-Oesophageal Reflux Disease of the European Society of Paediatric Gastroenterology and Nutrition.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-Analyses of Cisapride, Omeprazole and Ranitidine in the Treatment of GORD: Implications for Treating Patient Subgroups

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Working Party report of the Gastroenterological Society of Singapore. Part I--Helicobacter pylori and peptic ulcer disease in Singapore

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The combination of omeprazole, amoxycillin, and clarithromycin eradicates Helicobacter pylori in 95% of patients---7 days of therapy is as good as 10 days.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Triple therapy eradicated H. pylori equally in patients pretreated with omeprazole or ranitidine. A 12-month follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limited efficacy of omeprazole-based dual and triple therapy for Helicobacter pylori: a randomized trial employing "optimal" dosing.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depressing acid, deconjugating bile

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of effect of omeprazole in oral acenocoumarol anticoagulant therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review of Helicobacter pylori eradication regimens.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffuse alopecia associated with omeprazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, rand

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High effectiveness and safety of one-week antibiotic regimen in Helicobacter pylori eradication.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized study comparing omeprazole plus amoxycillin versus omeprazole plus clarithromycin for eradication of Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bullous skin reaction induced by omeprazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Treatment of acute peptic gastroduodenal ulcer: omeprazole is superior to ranitidine especially in the early phase of ulcer healing. A prospective controlled randomized serial endoscopy study]

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[One-week treatment with omeprazole, clarithromycin and amoxicillin: high efficacy in the eradication of Helicobacter pylori and cicatrization of duodenal ulcer]

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole-based antimicrobial therapies: results in 198 Helicobacter pylori-positive patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A seven-day Helicobacter pylori treatment regimen using clarithromycin, omeprazole and tripotassium dicitrato bismuthate

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Italian omeprazole triple therapy--a 1-week regimen.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pantoprazole versus omeprazole in one-week low-dose triple therapy for curve of H. pylori infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An increasing dose of omeprazole combined with amoxycillin cures Helicobacter pylori infection more effectively

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis. Results of a Scandinavian multicentre trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole-amoxycillin versus omeprazole-amoxycillin-clarithromycin in the eradication of Helicobacter pylori.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Triple therapy vs. amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: a multicenter, prospective, randomized, controlled study of efficacy and side effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-Helicobacter pylori Specific Antibody Immunohistochemistry Improves the Diagnostic Accuracy of Helicobacter pylori in Biopsy Specimen From Patients Treated With Triple Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of omeprazole in combination with several antimicrobial agents against clinical isolates of Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Helicobacter pylori infection with omeprazole-amoxicillin combination therapy versus ranitidine/sodium bicarbonate-amoxicillin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole and clarithromycin with and without metronidazole for the eradication of Helicobacter pylori.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of pharmacokinetic interaction between mexiletine and omeprazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accuracy of seven different tests for the diagnosis of Helicobacter pylori infection and the impact of H2-receptor antagonists on test results

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empiric therapy for gastroesophageal reflux disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central nervous system side effects after proton pump inhibitor treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What other regimens are under investigation to treat Helicobacter pylori infection?

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Canadian Helicobacter pylori consensus conference. Canadian Association of Gastroenterology

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anaphylaxis to omeprazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cure of Helicobacter pylori infection: role of duration of treatment with omeprazole and amoxicillin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One week treatment for Helicobacter pylori infection: a randomised study of quadruple therapy versus triple therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies: results of a randomized, double-blind, multicenter trial. Gastrointestinal Utilization Trial Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute renal failure due to omeprazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole in the long-term treatment of gastro-oesophageal reflux disease. A double-blind randomized dose-finding study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short-term omeprazole oral/amoxicillin intravenous therapy for Helicobacter pylori eradication: a lack of therapeutic effect.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimal dose of omeprazole in combination with amoxicillin in eradicating H. pylori and preventing relapses in duodenal ulcer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One week treatment with omeprazole, clarithromycin and tinidazole or lansoprazole, amoxicillin and metronidazole for cure of Helicobacter pylori infection in duodenal ulcer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolonged and profound acid inhibition is crucial in Helicobacter pylori treatment with a proton pump inhibitor combined with amoxicillin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi-centre double-blind study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment and prevention of relapse of mild oesophagitis with omeprazole and cisapride: comparison of two strategies

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid symptom relief in reflux oesophagitis: a comparison of lansoprazole and omeprazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful low-dose amoxycillin, metronidazole and omeprazole combination therapy in a population with a high frequency of metronidazole-resistant Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Helicobacter pylori infection with low or high dose omeprazole combined with amoxycillin and the effect of early retreatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helicobacter pylori: new developments and treatments

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug interactions with proton pump inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole is more effective than cimetidine in the prevention of recurrence of GERD-associated heartburn and the occurrence of underlying oesophagitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Effect of Omeprazole on Serum Concentrations of Theophylline, Pepsinogens A and C, and Gastrin in Elderly Duodenal Ulcer Patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Solo Investigator Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of the sulfoxidation of omeprazole by ketoconazole in poor and extensive metabolizers of S-mephenytoin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of omeprazole for resistant oesophagitis in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-week low-dose triple therapy for the eradication of Helicobacter pylori infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eradication of Helicobacter pylori: an objective assessment of current therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole plus clarithromycin and either tinidazole or tetracycline for Helicobacter pylori infection: a randomized prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Choice of long-term strategy for the management of patients with severe esophagitis: a cost-utility analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A one-week quadruple eradication regimen for Helicobacter pylori in routine clinical practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of ranitidine on the urea breath test: a controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Only four days of quadruple therapy can effectively cure Helicobacter pylori infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised controlled trial of ranitidine versus omeprazole in combination with antibiotics for eradication of Helicobacter pylori.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helicobacter pylori eradication--evaluation of triple therapy containing omeprazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute gout associated with omeprazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind trial of omeprazole and amoxicillin in the cure of Helicobacter pylori infection in gastric ulcer patients. The Ulcer Study Group, Germany

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention and treatment of nonsteroidal anti-inflammatory drug-induced gastropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eradicating Helicobacter pylori reduces hypergastrinaemia during long-term omeprazole treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immediate repeat course of amoxycillin, metronidazole and omeprazole to eradicate Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clarithromycin and omeprazole as helicobacter pylori eradication therapy in patients with H. pylori-associated gastric disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erythema nodosum caused by omeprazole.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole, azithromycin and either amoxycillin or metronidazole in eradication of Helicobacter pylori in duodenal ulcer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amoxycillin capsules with omeprazole for the eradication of Helicobacter pylori. Assessment of the importance of antibiotic dose timing in relation to meals

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fundic gland polyps developing during omeprazole therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Observation of gastric glandular cysts in the corpus mucosa of the stomach under omeprazole treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-week low-dose triple therapy vs. two-week medium-dose double therapy for H.pylori infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of omeprazole and ranitidine in the prevention of recurrence of benign esophageal stricture. Restore Investigator Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9777317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-199856030-00012

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33487903&oldid=2195407269"